Metal-carbenicillin framework-based nanoantibiotics with enhanced penetration and highly efficient inhibition of MRSA.

[1]  Xing-jie Liang,et al.  A traceable and bone-targeted nanoassembly based on defect-related luminescent mesoporous silica for enhanced osteogenic differentiation. , 2017, Journal of materials chemistry. B.

[2]  X. Qu,et al.  A Multinuclear Metal Complex Based DNase-Mimetic Artificial Enzyme: Matrix Cleavage for Combating Bacterial Biofilms. , 2016, Angewandte Chemie.

[3]  P. Chakrabarti,et al.  Shape engineering boosts antibacterial activity of chitosan coated mesoporous silica nanoparticle doped with silver: a mechanistic investigation. , 2016, Journal of materials chemistry. B.

[4]  K. Galvão,et al.  Chitosan Microparticles Exert Broad-Spectrum Antimicrobial Activity against Antibiotic-Resistant Micro-organisms without Increasing Resistance. , 2016, ACS applied materials & interfaces.

[5]  Zhenkun Zhang,et al.  Surface-Adaptive, Antimicrobially Loaded, Micellar Nanocarriers with Enhanced Penetration and Killing Efficiency in Staphylococcal Biofilms. , 2016, ACS nano.

[6]  V. Uskoković,et al.  Self-Setting Calcium Phosphate Cements with Tunable Antibiotic Release Rates for Advanced Antimicrobial Applications. , 2016, ACS applied materials & interfaces.

[7]  J. Duan,et al.  Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria , 2016, Scientific Reports.

[8]  S. Rice,et al.  tric oxide and antibiotic using polymeric nanoparticles † , 2016 .

[9]  X. Qu,et al.  Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response. , 2015, Chemical communications.

[10]  X. Qu,et al.  Near infrared-caged d-amino acids multifunctional assembly for simultaneously eradicating biofilms and bacteria. , 2015, Chemical communications.

[11]  E. Engel,et al.  Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[12]  C. Weng,et al.  pH-Triggered Controllable Release of Silver-Indole-3 Acetic Acid Complexes from Mesoporous Silica Nanoparticles (IBN-4) for Effectively Killing Malignant Bacteria. , 2015, Molecular pharmaceutics.

[13]  M. Zhang,et al.  Versatile antimicrobial peptide-based ZnO quantum dots for in vivo bacteria diagnosis and treatment with high specificity. , 2015, Biomaterials.

[14]  H. Smyth,et al.  Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms. , 2015, Molecular pharmaceutics.

[15]  Yong Li,et al.  pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. , 2015, ACS nano.

[16]  Jeffery E. Raymond,et al.  Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections. , 2015, Nanoscale.

[17]  Xiaogang Qu,et al.  Graphene quantum dots-band-aids used for wound disinfection. , 2014, ACS nano.

[18]  Mitra S. Ganewatta,et al.  Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria. , 2014, Journal of the American Chemical Society.

[19]  Adam J Friedman,et al.  Nanotechnology as a therapeutic tool to combat microbial resistance. , 2013, Advanced drug delivery reviews.

[20]  Kieron M. G. O'Connell,et al.  Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials. , 2013, Angewandte Chemie.

[21]  Erik N. Taylor,et al.  Enhanced Efficacy of Superparamagnetic Iron Oxide Nanoparticles Against Antibiotic‐Resistant Biofilms in the Presence of Metabolites , 2013, Advanced materials.

[22]  K. Lewis.  Platforms for antibiotic discovery , 2013, Nature Reviews Drug Discovery.

[23]  A. Chattopadhyay,et al.  Membrane‐Directed High Bactericidal Activity of (Gold Nanoparticle)–Polythiophene Composite for Niche Applications Against Pathogenic Bacteria , 2013, Advanced healthcare materials.

[24]  E. Azzopardi,et al.  The enhanced permeability retention effect: a new paradigm for drug targeting in infection. , 2013, The Journal of antimicrobial chemotherapy.

[25]  S. Rice,et al.  Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms. , 2012, Angewandte Chemie.

[26]  H. Maeda.  Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting , 2012, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[27]  Junxiang Zhang,et al.  Ratiometric fluorescence detection of pathogenic bacteria resistant to broad-spectrum β-lactam antibiotics. , 2012, Angewandte Chemie.

[28]  Young Jik Kwon,et al.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[30]  Margherita Sosio,et al.  Antibiotic discovery in the twenty-first century: current trends and future perspectives , 2010, The Journal of Antibiotics.

[31]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[32]  M. Doble,et al.  Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[33]  Rongrong Liu,et al.  Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors. , 2008, Mini reviews in medicinal chemistry.

[34]  A. Clatworthy,et al.  Targeting virulence: a new paradigm for antimicrobial therapy , 2007, Nature Chemical Biology.

[35]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[36]  Charles Y. Tan,et al.  A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model , 2006, Infection and Immunity.

[37]  S. Meroueh,et al.  Bacterial Resistance to β‐Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity , 2005 .

[38]  Samy O Meroueh,et al.  Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. , 2005, Chemical reviews.

[39]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[40]  L. Cartee,et al.  Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics. , 2004, Current medicinal chemistry.

[41]  Tim Tolker-Nielsen,et al.  Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. , 2003, Current opinion in biotechnology.

[42]  B. Ersbøll,et al.  Quantification of biofilm structures by the novel computer program COMSTAT. , 2000, Microbiology.

[43]  L. Kotra,et al.  Evaluation of inhibition of the carbenicillin‐hydrolyzing β‐lactamase PSE‐4 by the clinically used mechanism‐based inhibitors , 2000, FEBS letters.